跳至主要内容
临床试验/NCT00502255
NCT00502255已完成不适用

Telemonitoring in Patients With Heart Failure

Maastricht University Medical Center4 个研究点 分布在 1 个国家目标入组 382 人开始时间: 2007年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
382
试验地点
4
主要终点
To what extent does the use of Health Buddy result in a decrease in hospital admissions?

研究概览

简要总结

The purpose of this study is to investigate if telemonitoring results in a decrease in hospital admissions, with equal quality of care defined as mortality, quality of life and unplanned visits with caregivers. Telemonitoring is expected to be more cost-effective than usual care in patients with heart failure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients > 18 years
  • Patients with heart failure NYHA classification II-III-IV
  • Patient experienced a period of fluid retention
  • Patient is treated by a cardiologist
  • Patient is followed-up by a heart failure nurse
  • Adequate knowledge of the Dutch language
  • Patient has an active telephone connection, preferably analogue
  • Patient is mental competent
  • Patient has the disposal of a balance

排除标准

  • Patients suffering from COPD, Gold classification 3 or 4
  • Patient is a dialysis patient
  • Patient has a visual restriction to read the dialogues on the Health Buddy
  • Patient is hard of hearing or deaf
  • Patient suffers from a lethal sickness with a prognosis < 1 year
  • Patient participates in another trial
  • Patient needs a hospital admission on short time, i.e., < 3 months
  • Patient used the Health Buddy in an earlier stage
  • Patient is an illiterate person.

结局指标

主要结局

To what extent does the use of Health Buddy result in a decrease in hospital admissions?

时间窗: one year

To what extent will the amount of planned contacts decrease without an increase of unplanned contacts?

时间窗: one year

To what extent is Health Buddy® more cost-effective than usual care?

时间窗: one year

次要结局

  • What is the effect of Health Buddy® in patients with heart failure in regard to drug consumption and therapy compliance and level of knowledge, and quality of life?(one year)
  • To what extent is it - based on patients' characteristics - possible to identify patient with benefits?(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Josiane Boyne

RN,MA

Maastricht University Medical Center

研究点 (4)

Loading locations...

相似试验

Telemonitoring in Patients With Heart Failure | 临床试验